Seelos Therapeutics (SEEL) Short Interest Ratio & Short Volume $0.27 -0.02 (-8.03%) (As of 12/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Seelos Therapeutics Short Interest DataSeelos Therapeutics (SEEL) has a short interest of 52,500 shares, representing 4.73% of the float (the number of shares available for trading by the public). This marks a -69.28% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 174,745 shares to cover all short positions.Current Short Interest52,500 sharesPrevious Short Interest170,900 sharesChange Vs. Previous Month-69.28%Dollar Volume Sold Short$67,200.00Short Interest Ratio0.1 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares372,000 sharesFloat Size1,110,000 sharesShort Percent of Float4.73%Today's Trading Volume21,068 sharesAverage Trading Volume174,745 sharesToday's Volume Vs. Average12% Short Selling Seelos Therapeutics? Sign up to receive the latest short interest report for Seelos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSEEL Short Interest Over TimeSEEL Days to Cover Over TimeSEEL Percentage of Float Shorted Over Time Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Seelos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202452,500 shares $67,200.00 -69.3%4.7%0.1 $1.28 9/30/2024170,900 shares $641,729.50 +46.2%29.7%0.3 $3.76 9/15/2024116,900 shares $23,263.10 -71.2%1.7%0 $0.20 8/31/2024405,500 shares $118,324.90 +354.1%6.0%0.2 $0.29 8/15/202489,300 shares $24,111.00 -38.6%1.3%0 $0.27 7/31/2024145,400 shares $55,979.00 -50.7%5.4%0.3 $0.39 Get the Latest News and Ratings for SEEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seelos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024295,000 shares $152,987.00 +116.8%10.9%0.6 $0.52 6/30/2024136,100 shares $81,251.70 -36.9%5.1%0.3 $0.60 6/15/2024215,600 shares $195,527.64 -21.6%8.0%2.2 $0.91 5/31/2024275,000 shares $330,000.00 +180.0%11.8%3.5 $1.20 5/15/202498,200 shares $28,497.64 -90.6%4.2%1.4 $0.29 4/30/20241,040,000 shares $290,160.00 +51.9%6.9%2.5 $0.28 4/15/2024684,600 shares $298,485.60 -5.8%5.5%1.6 $0.44 3/31/2024726,800 shares $429,538.80 -10.8%5.8%1.6 $0.59 3/15/2024815,000 shares $812,962.50 +178.2%6.5%1.9 $1.00 2/29/2024293,000 shares $377,970.00 -5.6%2.4%0.6 $1.29 2/15/2024310,500 shares $258,056.55 -24.1%2.6%0.4 $0.83 1/31/2024409,100 shares $417,282.00 -70.1%3.4%0.6 $1.02 1/15/20241,370,000 shares $1.93 million +61.8%14.4%2.1 $1.41 12/31/2023846,900 shares $1.18 million -1.4%8.9%1.4 $1.39 12/15/2023859,300 shares $1.34 million +6.2%9.2%1.5 $1.56 11/30/2023808,800 shares $1.02 million -91.6%11.2%1.4 $1.26 11/15/20239,650,000 shares $34.88 million +16.0%N/A1.6 $3.62 10/31/20238,320,000 shares $1.55 million -0.8%N/A1.6 $0.19 10/15/20238,390,000 shares $1.54 million -18.0%N/A1.8 $0.18 9/30/202310,230,000 shares $1.88 million +66.3%N/A2.5 $0.18 9/15/20236,150,000 shares $5.67 million +2.0%N/A2 $0.92 8/31/20236,030,000 shares $6.57 million +10.4%N/A6.6 $1.09 8/15/20235,460,000 shares $6.39 million -2.0%N/A6.3 $1.17 7/31/20235,570,000 shares $8.52 million +5.3%N/A7.5 $1.53 7/15/20235,290,000 shares $6.98 million -4.3%N/A7.8 $1.32 6/30/20235,530,000 shares $6.61 million -3.0%N/A10 $1.20 6/15/20235,700,000 shares $5.99 million +4.0%N/A11.1 $1.05 5/31/20235,480,000 shares $5.10 million -5.7%N/A11.7 $0.93 5/15/20235,810,000 shares $5.28 million -11.0%N/A11.2 $0.91 4/30/20236,530,000 shares $4.51 million +3.8%N/A12.6 $0.69 4/15/20236,290,000 shares $4.91 million -6.1%N/A11.6 $0.78 3/31/20236,700,000 shares $4.63 million -1.0%N/A12 $0.69 3/15/20236,770,000 shares $4.23 million +7.5%N/A11.1 $0.63 2/28/20236,300,000 shares $4.98 million +5.7%N/A9.2 $0.79Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem 2/15/20235,960,000 shares $4.41 million +4.4%N/A9 $0.74 1/31/20235,710,000 shares $4.64 million -0.4%N/A9.1 $0.81 1/15/20235,730,000 shares $5.21 million No ChangeN/A8.8 $0.91 12/30/20225,730,000 shares $3.89 million -3.2%N/A9 $0.68 12/15/20225,920,000 shares $6.45 million +1.7%N/A9.3 $1.09 11/30/20225,820,000 shares $4.76 million +4.7%N/A8.8 $0.82 11/15/20225,560,000 shares $5.00 million -3.1%N/A8 $0.90 10/31/20225,740,000 shares $4.99 million -10.0%N/A6 $0.87 10/15/20226,380,000 shares $5.79 million +0.2%N/A6.4 $0.91 9/30/20226,370,000 shares $6.56 million +1.8%N/A6.3 $1.03 9/15/20226,260,000 shares $8.01 million +11.0%N/A4.7 $1.28 8/31/20225,640,000 shares $6.37 million +5.8%N/A4.3 $1.13 8/15/20225,330,000 shares $5.20 million -12.2%N/A3.9 $0.98 7/31/20226,070,000 shares $5.10 million -7.8%N/A5.1 $0.84 7/15/20226,580,000 shares $5.90 million +2.5%N/A5.1 $0.90 6/30/20226,420,000 shares $4.37 million -32.0%N/A4.7 $0.68 6/15/20229,440,000 shares $6.65 million -1.7%N/A7.1 $0.70 5/31/20229,600,000 shares $6.23 million +5.5%N/A7.4 $0.65 5/15/20229,100,000 shares $5.13 million +2.8%N/A6.3 $0.56 4/30/20228,850,000 shares $5.49 million +8.6%8.8%5.5 $0.62 4/15/20228,150,000 shares $6.49 million +6.1%8.1%4.7 $0.80 3/31/20227,680,000 shares $6.43 million -2.5%7.6%4.2 $0.84 3/15/20227,880,000 shares $7.01 million +11.6%7.8%3.9 $0.89 2/28/20227,060,000 shares $7.48 million +9.3%7.1%3.2 $1.06 2/15/20226,460,000 shares $7.82 million +5.0%6.5%2.7 $1.21 1/31/20226,150,000 shares $7.01 million +19.7%6.6%2.4 $1.14 1/15/20225,140,000 shares $7.25 million -5.7%6.9%1.9 $1.41 12/31/20215,450,000 shares $8.88 million -4.7%N/A1.8 $1.63 12/15/20215,720,000 shares $9.44 million -8.8%7.7%1.5 $1.65 11/30/20216,270,000 shares $10.85 million +5.9%8.4%1.5 $1.73 11/15/20215,920,000 shares $12.49 million -3.6%7.9%1.5 $2.11 10/29/20216,140,000 shares $13.26 million +13.1%8.2%1.7 $2.16 10/15/20215,430,000 shares $12.27 million +14.1%7.3%1.5 $2.26 9/30/20214,760,000 shares $11.47 million +24.9%6.4%1.5 $2.41 9/15/20213,810,000 shares $7.54 million +1.9%5.1%1.3 $1.98 8/31/20213,740,000 shares $8.23 million -3.9%5.0%1.5 $2.20 8/13/20213,890,000 shares $7.82 million -3.7%5.2%1.2 $2.01 7/30/20214,040,000 shares $9.09 million +2.0%5.4%1 $2.25 7/15/20213,960,000 shares $9.66 million -19.5%5.3%0.9 $2.44 6/30/20214,920,000 shares $12.99 million +75.7%6.6%1 $2.64 6/15/20212,800,000 shares $8.71 million -22.7%3.8%0.5 $3.11 5/28/20213,620,000 shares $11.15 million +11.7%4.9%0.3 $3.08 5/14/20213,240,000 shares $14.97 million -27.0%N/A0.3 $4.62 4/30/20214,440,000 shares $27.62 million -17.0%N/A0.5 $6.22 4/15/20215,350,000 shares $25.79 million +84.5%N/A0.5 $4.82 3/31/20212,900,000 shares $14.38 million +16.5%N/A0.3 $4.96 3/15/20212,490,000 shares $11.83 million -3.5%N/A0.3 $4.75 2/26/20212,580,000 shares $7.87 million +5.7%N/A0.8 $3.05 2/12/20212,440,000 shares $9.54 million +22.0%N/A0.8 $3.91 1/29/20212,000,000 shares $4.50 million +34.2%N/A0.8 $2.25Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem 1/15/20211,490,000 shares $2.15 million -9.2%N/A0.7 $1.44 12/31/20201,640,000 shares $2.54 million +145.5%N/A1.3 $1.55 12/15/2020668,100 shares $855,168.00 +22.5%N/A0.4 $1.28 11/30/2020545,200 shares $561,556.00 +13.2%N/A0.4 $1.03 11/15/2020481,800 shares $412,998.96 +21.0%N/A0.4 $0.86 10/30/2020398,100 shares $306,497.19 +8.0%N/A0.3 $0.77 10/15/2020368,500 shares $327,965.00 +4.6%N/A0.2 $0.89 9/30/2020352,200 shares $330,011.40 +29.8%N/A0.2 $0.94 9/15/2020271,400 shares $185,909.00 -35.6%N/A0.2 $0.69 8/31/2020421,300 shares $383,383.00 +121.7%N/A0.3 $0.91 8/14/2020190,000 shares $195,700.00 -53.1%N/A0.2 $1.03 7/31/2020405,000 shares $469,800.00 -32.6%N/A0.3 $1.16 7/15/2020600,500 shares $606,505.00 -0.4%N/A0.4 $1.01 6/30/2020602,700 shares $608,727.00 -9.9%N/A0.4 $1.01 6/15/2020669,000 shares $863,010.00 -32.1%N/A0.4 $1.29 5/29/2020985,400 shares $1.24 million +63.1%N/A0.8 $1.26 5/15/2020604,100 shares $447,034.00 +9.4%N/A0.5 $0.74 4/30/2020552,000 shares $391,920.00 +6.9%N/A0.5 $0.71 4/15/2020516,500 shares $246,732.05 -23.7%N/A0.7 $0.48 3/31/2020677,200 shares $345,372.00 -11.8%N/A0.9 $0.51 3/13/2020768,100 shares $345,645.00 +3.6%N/A1 $0.45 2/28/2020741,100 shares $355,728.00 -56.7%N/A0.9 $0.48 2/14/20201,710,000 shares $1.47 million +39.0%N/A2.2 $0.86 1/31/20201,230,000 shares $1.07 million +3.4%N/A1.9 $0.87 1/15/20201,190,000 shares $916,300.00 +13.3%5.9%2.3 $0.77 12/31/20191,050,000 shares $1.28 million +50.1%N/A2.1 $1.22 SEEL Short Interest - Frequently Asked Questions What is Seelos Therapeutics' current short interest? Short interest is the volume of Seelos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 52,500 shares of SEEL short. 4.73% of Seelos Therapeutics' shares are currently sold short. Learn More on Seelos Therapeutics' current short interest. What is a good short interest percentage for Seelos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.73% of Seelos Therapeutics' floating shares are currently sold short. Is Seelos Therapeutics' short interest increasing or decreasing? Seelos Therapeutics saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 52,500 shares, a decrease of 69.3% from the previous total of 170,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Seelos Therapeutics' float size? Seelos Therapeutics currently has issued a total of 372,000 shares. Some of Seelos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Seelos Therapeutics currently has a public float of 1,110,000 shares. How does Seelos Therapeutics' short interest compare to its competitors? 4.73% of Seelos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Seelos Therapeutics: NexImmune, Inc. (1.39%), PainReform Ltd. (9.33%), TC Biopharm (Holdings) Plc (3.62%), TFF Pharmaceuticals, Inc. (3.95%), Smart for Life, Inc. (11.90%), eFFECTOR Therapeutics, Inc. (16.84%), Alvotech (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Seelos Therapeutics stock? Short selling SEEL is an investing strategy that aims to generate trading profit from Seelos Therapeutics as its price is falling. SEEL shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Seelos Therapeutics? A short squeeze for Seelos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SEEL, which in turn drives the price of the stock up even further. How often is Seelos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SEEL, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies NEXI Short Interest PRFX Short Interest TCBP Short Interest TFFP Short Interest SMFL Short Interest EFTR Short Interest ATNFW Short Interest ALVOW Short Interest ALVO Short Interest ACABW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SEEL) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seelos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seelos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
